Updated analyses showed the 5-year overall survival to be 43 % in group 1 and 55 % in group 2 ( hazard ratio 0.73 , 95 % confidence interval 0.54-0 .99 , P = 0.04 ) , where the median follow-up of censored patients was 61.6 months .
